Veterans with mental illness may get therapy from trained peers
NCT ID NCT03467243
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether peer specialists—people who have serious mental illness themselves and are trained to help others—can effectively deliver two types of therapy: Cognitive Behavioral Social Skills Training (CBSST) and Social Skills Training (SST). The goal is to help veterans with conditions like schizophrenia or bipolar disorder improve their social functioning and quality of life. The trial involved 191 veterans and compared peer-delivered therapy to usual care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cognitive Behavioral Social Skills Training (CBSST) and Social Skills Training (SST) delivered by peer specialists
- What this could lead to
- If effective, this could expand access to proven therapy for veterans with serious mental illness by using trained peer specialists instead of only doctors or therapists.
- What could go wrong
- This is a completed trial with 191 participants, but results are not yet widely confirmed. Peer delivery may not be as effective as professional-led therapy, and individual outcomes may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
191 people
The number who actually took part.
- Started
-
Aug 2018
- Finished
-
Sep 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Voluntary informed consent (must be able to be given by the patient) * Primary diagnosis of SMI documented in the medical record * schizophrenia * schizoaffective disorder * bipolar disorder with psychotic features * Fluent in English so as to be able to complete testing Exclusion Criteria: * Medication changes in the prior month * Current or recent (within the past year) CBSST, CBT, or SST (so any skill knowledge and any improvement in outcome can be attributed to SST- or CBSST-Peer rather than participation in other forms of current or recent CBT or SST interventions) * Level of care at baseline that interferes with outpatient participation * Current hospitalization for psychiatric, substance use or physical illness * hospitalized subjects will be invited to participate 1 month after discharge * Severe and/or unstable mental illness as indicated during informed consent process by inability to pass the Blessed measure in the first visit * Cognitive impairment as indicated by inability to pass the 10 item T/F measure about informed consent * Women who are pregnant will be excluded from this study * Incarcerated Veterans will be excluded from this study * Veterans with impaired decision making capabilities will be excluded from this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder with psychotic features are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug
- A shot every few weeks? new drug tested for schizophrenia